Clinical Research Technician – Translational Studies for the ONCOMAO Project (17,5h/week)

REF: 25-196_SS_AA

About the research group

The succesful candidate will join the research group Resistance and progression mechanisms in prostate cancer lead by Dr Alvaro Aytes in IDIBELL. Dr Aytes’s research exploits genetically engineered mouse prostate cancer models to uncover mechanisms of progression towards advanced, therapy resistant prostate cancer. The group uses computational approaches for cross-species analysis of phenotypic and preclinical data from a range of high-throuhput molecular profiling. Of particular interest is the role of the epigenetically modulated changes in gene regulatory programs in therapy resistance. The lab is also interested in identifying molecular biomarkers for patients stratification and to predict responses to standard of care and experimental therapies. Finally the lab is also heavily invested in identifying new targets through synthetic lethal interactions with AR signalling inhibitors and other approved drugs using CRISPR/Cas screening s in vitro and in vivo.

About the role

The candidate will participate in the elaboration of the necessary documents to obtain authorization for the clinical trial in cancer patients and posteriorly, the reporting of translational data, coordinating the clinical and translational databases. Additionally, he or she will help to characterize the in vivo efficacy of the experimental drug in different in vitro cellular and in vivo animal models, using syngeneic and xenograft models. The candidate will characterize the cell growth inhibitory activity in different human tumor cells lines and of potential immunomodulatory effect in human cells.

Job requirements

Professional experience

• Experience in Medical Oncology.

Education and training

•  Medical Oncology degree. 

Technical & soft skills

• Good digital skills, focused on data management and clinical data.
• Experience as Data Entry and maintenance of databases.
• Previous formation on clinical trials.

Languages

• Good command of the English language.
• Good command of Spanish and Catalan.

We will value, but not required

• Master in Medical Oncology will be value.
• Teamwork oriented, with high capabilities to collaborate with different professional profiles.
• Good communication skills.

What do we offer

•  No. of positions: 1
•  Estimated start date: 02/01/2026.
•  Contract duration: Permanent by project.
•  Estimated annual gross salary: 18.000€
•  You will be part of a multicultural team. We have a fun loving and friendly international work environment.
•  Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
•  Possibility to work some days in remote -Teleworking
•  26 working days of holiday per year
•  System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
•  Paid leave package
•  Benefits of constant training are offered
• We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by 02/01/2026

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).